Estimated read time: 4-5 minutes
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
[STK]
[IN] HEA BIO PHA
[SU] SVY
-- WITH PHOTO -- TO BUSINESS, HEALTH, AND MEDICAL EDITORS:
Content That Impacts Lives: DCL and The Rockley Group Present New Data
on Content Challenges in the Life Sciences and Healthcare Industry
NEW YORK, March 25, 2014 /PRNewswire/ -- Concerns over different
formats, multiple channel delivery, and potentially dangerous
inconsistencies in content have come to the forefront in a new survey
of life sciences and healthcare professionals. The survey was
conducted by Data Conversion Laboratory (DCL), an industry leader in
organizing and converting content into digital formats, in association
with The Rockley Group, specializing in the development and
implementation of content management strategies and solutions.
(Logo: http://photos.prnewswire.com/prnh/20140325/PH89597LOGO-a )
(Logo: http://photos.prnewswire.com/prnh/20140325/PH89597LOGO-b )
"Today, consumers seek out informational content, for example on
prescriptions, not only from the paper insert that accompanies the
medication, but digitally as well," says Ann Rockley, founder and
president, The Rockley Group. "It's important that pharmaceutical
companies - and any company in the life sciences and healthcare
industry - provide information that is accurate and consistent across
all channels readily accessible to the consumer. Not doing so can risk
lives."
It isn't just consumer-facing content that's affected. As companies
struggle to keep up with shifting requirements on the sharing of drug,
medical device and patient record information with regulators,
physicians and pharmacies, accuracy and consistency across channels is
of utmost priority. More than 95% of survey respondents identified
inconsistencies and inaccuracies as the top issues affecting their
company's content.
"To meet this challenge, the life sciences and healthcare industry
must first thoroughly organize their content, for example, through
elimination of redundant versions. This creates an ability to figure
out the rules that need to be applied once the digital conversion
process begins," says Mark Gross, founder and president, Data
Conversion Laboratory. "This 'clean slate' start is at the heart of
what DCL does, and is imperative to an efficient, cost-effective
content management strategy that allows for ease of distribution
across all channels."
"Intelligent content best practices, resulting in content that is
reusable, trackable, retrievable, and automatically publishable to
multiple channels, ensures that healthcare companies can meet the
increasing requirements for regulatory control and provide greater
customer satisfaction," says Ann Rockley.
Two of the major issues highlighted by the survey, "Content Challenges
in the Life Sciences and Healthcare Industry," reflect these
insights: approximately 56% of respondents reported that their
biggest content concern is seamless delivery in different formats
(print, web, mobile, etc.) while 55.4% pointed to inconsistencies as
their greatest issue, as it is one of the more challenging problems to
address in a manual process.
"A solid content management strategy needs to take into consideration
the complexities inherent to data found throughout the life sciences
and healthcare industries. Combining the best content management tools
with a precise conversion methodology allows inconsistencies to be
tracked and corrected across channels in a much more efficient manner
than simple document organization ever could," added Mr. Gross.
The full results of the survey will be presented by Ann Rockley at the
Intelligent Content Life Sciences and Healthcare Conference on May 8
in San Francisco, CA.
About Data Conversion Laboratory, Inc.
DCL (www.dclab.com) is a leader in helping organizations maximize the
value of their content assets investment through digitization and
organization, making reuse easier and providing greater accessibility.
DCL's process ensures that content quality is vastly improved, systems
are future-proofed, redundancies are eliminated and revenue
opportunities are expanded. With expertise across industries including
life sciences, government, manufacturing, technology and professional
organizations, DCL uses its advanced technology and U.S.-based project
management teams to help solve the most complex conversion challenges
securely, accurately and on time. Founded in 1981, DCL has been named
one of EContent's Top 100 Companies in the Digital Content Industry
for three years running, 2011-2013.
About The Rockley Group, Inc.
The Rockley Group, Inc. (www.rockley.com) is an internationally
recognized content strategy consultancy that has been helping
pharmaceutical, medical devices, and healthcare providers to move to
structured reusable content strategies and content management for more
than 20 years. The Rockley Group has worked with regulatory, labeling,
and customer engagement materials. The Rockley Group has defined best
practices for content reuse, intelligent content development,
multichannel / multi-device delivery, eBook production, and content
management. Ann Rockley, known as the "mother" of content strategy,
introduced the concept of content strategy in 2001 with her
best-selling book, "Managing Enterprise Content: A Unified Content
Strategy," (www.managingenterprisecontent.com) now in its second
edition.
Contact: Ariane Doud, Warner Communications, (978) 283-2674, Email
Read more news from Data Conversion Laboratory, Inc.
SOURCE Data Conversion Laboratory, Inc.
-0- 03/25/2014
/Photo: http://photos.prnewswire.com/prnh/20140325/PH89597LOGO-a
http://photos.prnewswire.com/prnh/20140325/PH89597LOGO-b
PRN Photo Desk, photodesk@prnewswire.com
CO: Data Conversion Laboratory, Inc.
ST: New York
IN: HEA BIO PHA
SU: SVY
PRN
-- PH89597 --
0000 03/25/2014 12:35:00 EDT http://www.prnewswire.com
Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
